Question: An analyst has gathered data on valuation multiples for Merck (MRK) and three other pharmaceutical companles, which will serve as comparable firms: Pfizer (PFE), Ell

 An analyst has gathered data on valuation multiples for Merck (MRK)

An analyst has gathered data on valuation multiples for Merck (MRK) and three other pharmaceutical companles, which will serve as comparable firms: Pfizer (PFE), Ell Lilly (LLY), and Sanof- Aventis (SNY Valuation multiples PFE MRK SNY Comparable Company symbol Price/Earnings9.08 Price/Book Price/Sales Enterprise LLY 1.96 2.78 9.93 15.42 1.48 2.05 5.64 846 3.62 1.63 4.94 10.15 1.12 1.87 5.33 average 11.34 2.07 1.85 5.30 Value/EBITDA The analyst is estlmating the value of the equity Insol, a private pharmaceutical company that has $200M In EBITDA and Is financed with $300M In debt. Using the comparable average, the equity of this company would be valued at O $480M O $560M O $760M O $1,060M

Step by Step Solution

There are 3 Steps involved in it

1 Expert Approved Answer
Step: 1 Unlock blur-text-image
Question Has Been Solved by an Expert!

Get step-by-step solutions from verified subject matter experts

Step: 2 Unlock
Step: 3 Unlock

Students Have Also Explored These Related Finance Questions!